Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women

Recruiting N/A Interventional Study
Vulnerable Population
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
200 (estimated)
Sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Globally, women accounted for more than half of people living with HIV (53%) in 2022. In France, 54% of new infections were heterosexual in 2022, 71% of whom were born abroad, mainly in sub-Saharan Africa (74%). Among women, 80% of new cases were born abroad, of which at least 30% contracted HIV after arriving in France, often in connection with social vulnerability as shown by the French study Pa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Female, 18 years of age or older * Living in Ile de France * In a vulnerable situation with at least one of the following two situations: * Social/economic vulnerability (without personal residence or residence permit of less than 2 years or expiring in less than 1 year or …
Contacts

Yasmine DUDOIT, Project manager

+33 (0)1 42 16 41 81

yasmine.dudoit@aphp.fr

CONTACT

Christine KATLAMA, Professor

+33 (0)1 42 16 01 71

christina.katlama@aphp.fr

CONTACT